TOKYO (Reuters) - U.S. private equity firm Bain Capital said it may withdraw its tender offer proposal for Japanese IT firm ...

Bain Capital is considering withdrawing its tender offer for Japanese IT firm Fuji Soft after rival U.S. private equity giant ...

Private equity firm Bain Capital (BCSF) is paying $3.4 billion to buy a 350-year-old Japanese drugs group fighting diabetes ...

Bain Capital will partner with Milacron’s current owner, Hillenbrand, Inc. (NYSE: HI), who will remain a significant investor in the business to accelerate the Company’s continued growth. Bain Capital ...

The carve-out acquisition will allow Bain to capitalize on the “promising signs for growth” in the Japanese life sciences ...

We believe Bain Capital, with its proven track record of building true market leaders in services and distribution, is the right partner to ... them thrive since its founding in 1984.

Bain Capital said the deal came about following several recent initiatives by the Japanese government and regulators to ...

“Milacron is an iconic American manufacturing business with a 50-year legacy of driving innovation in plastics,” said Matt Evans, a partner at Bain Capital Special Situations in a statement.

In Friday’s acquisition announcement, Ricky Sun, a partner at Bain Capital Life Sciences, said the investment firm believes there are promising signs for growth and untapped opportunities in ...